Co-Founder & Ceo
CurrentEVQLV is a pioneering company at the intersection of AI and antibody design. Our mission is to make it easy for any antibody discovery researcher to quickly incorporate AI to address discovery and engineering challenges.As the CEO, I drive the company's vision towards a future where healthcare solutions are more personalized. As a team, we spearheaded the development and commercialization of our proprietary AI platform. We successfully secured funding through multiple rounds of investment. We established strategic partnerships with leading pharmaceutical companies, biotechs, universities, and contract research organizations. Leading EVQLV has been a journey of relentless innovation, meaningful impact, and strategic growth. We remain dedicated to pushing the boundaries of what's possible in healthcare.